Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-046332

Chief Executive Officer sold 5,500 shares at an average $16.49 ($90,704)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2017-07-24 Sale −2,500 $16.89 $42,225 453,578 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-07-24 Sale −300 $17.32 $5,196 453,278 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-07-25 Sale −2,500 $15.97 $39,925 450,778 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2017-07-25 Sale −200 $16.79 $3,358 450,578 I: show line 4 in the form
Open-market sales · 5,500 sh · avg $16.49 · $90,704
Loading xslF345X03/doc4.xml…